Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 60.22B 8.97B 7.67B 7.17B 6.56B 12.39B 856B 12.53B 84.65B 32.99B 431B 33.69B 32.96B 1,429B | P/E 2026 * |
45.6x | P/E 2027 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise Value | 55.51B 8.27B 7.07B 6.61B 6.05B 11.42B 789B 11.55B 78.03B 30.41B 397B 31.06B 30.38B 1,317B | EV / Sales 2026 * |
6.87x | EV / Sales 2027 * | 5.77x |
| Free-Float |
61.13% | Yield 2026 * |
0.8% | Yield 2027 * | 1.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.12B | |
| -1.06% | +4.27% | +73.34% | +125.12% | 1,111B | |
| +0.53% | +4.10% | +52.35% | +65.45% | 658B | |
| +0.48% | +6.18% | +26.21% | +81.27% | 467B | |
| +0.92% | +4.97% | +42.94% | +43.69% | 369B | |
| +1.25% | +4.00% | +25.87% | +42.82% | 301B | |
| +3.02% | +7.92% | +4.24% | +16.06% | 256B | |
| -0.36% | +5.45% | +50.57% | +72.33% | 240B | |
| +2.86% | +5.27% | -15.42% | -52.34% | 207B | |
| +1.38% | +7.09% | +29.62% | +94.90% | 182B | |
| Average | +1.03% | +4.49% | +32.19% | +54.37% | 421.22B | |
| Weighted average by Cap. | +1.03% | +4.68% | +44.12% | +73.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.2B 1.03B 963M 881M 1.66B 115B 1.68B 11.36B 4.43B 57.86B 4.52B 4.43B 192B | 9.78B 1.46B 1.25B 1.17B 1.07B 2.01B 139B 2.04B 13.75B 5.36B 70.02B 5.47B 5.36B 232B |
| Net income | 1.36B 203M 173M 162M 148M 280M 19.36B 283M 1.91B 746M 9.74B 762M 745M 32.3B | 1.79B 267M 228M 214M 195M 369M 25.48B 373M 2.52B 982M 12.83B 1B 981M 42.53B |
| Net Debt | -4.71B -701M -600M -561M -513M -969M -66.92B -979M -6.62B -2.58B -33.69B -2.63B -2.58B -112B | -3.73B -555M -475M -444M -406M -767M -52.99B -775M -5.24B -2.04B -26.67B -2.09B -2.04B -88.43B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
